Autolus Therapeutics plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Autolus Therapeutics plc - ADR: Is Infosys Ltd. worth buying?
Item: Autolus Therapeutics plc - ADR
Rating: 1.31425
Author: Trendlyne DVM scores

about

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

1.44 0.03 (2.13%)

71.20% Fall from 52W High

7.6M

XNAS Volume

High volume today

XNAS 03 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.0 / 100

Technically Bearish

34.6 / 100

1Yr Price target upside is 568%

9 analysts

Autolus Therapeutics plc ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Autolus Therapeutics plc - ADR Live Stock Price Today, Share Analysis and Chart

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

71.20% Fall from 52W High

High volume today

SWOT Analysis

Autolus Therapeutics plc ADR Live Price Chart